<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55-ijms-21-07078">
 <label>55.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Latacz</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lubelska</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jastrzębska-Więsek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Partyka</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Marć</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Satała</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wilczyńska</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kotańska</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Więcek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kamińska</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The 1,3,5-triazine derivatives as innovative chemical family of 5-HT6 serotonin receptor agents with therapeutic perspectives for cognitive impairment</article-title>
  <source>Int. J. Mol. Sci.</source>
  <year>2019</year>
  <volume>20</volume>
  <elocation-id>3420</elocation-id>
  <pub-id pub-id-type="doi">10.3390/ijms20143420</pub-id>
 </element-citation>
</ref>
